AstraZeneca – AstraZeneca PLC ADR outperforms market on robust buying and selling day

The AstraZeneca PLC ADR
(AZN),
+0.59%
inched 0.59% increased to $52.55 Thursday, on what proved to be an all-around blended buying and selling session for the stock market, with the NASDAQ Composite Index
COMP,
+0.55%
rising 0.55% to 13,530.91 and the Dow Jones Industrial Common
DJIA,
-0.04%
falling 0.04% to 31,176.01. AstraZeneca PLC ADR closed $12.39 under its 52-week excessive ($64.94), which the corporate achieved on July 20th.

The ADR outperformed a few of its rivals Thursday, as AbbVie Inc.
ABBV,
-1.21%
fell 1.21% to $111.26, Amgen Inc.
AMGN,
-0.13%
fell 0.13% to $252.03, and Gilead Sciences Inc.
GILD,
-1.49%
fell 1.49% to $66.98. Buying and selling quantity (16.Zero M) eclipsed its 50-day common quantity of 11.2 M.